These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Production methodologies of polymeric and hydrogel particles for drug delivery applications. Lima AC; Sher P; Mano JF Expert Opin Drug Deliv; 2012 Feb; 9(2):231-48. PubMed ID: 22250602 [TBL] [Abstract][Full Text] [Related]
24. A Review of Injectable Polymeric Hydrogel Systems for Application in Bone Tissue Engineering. Kondiah PJ; Choonara YE; Kondiah PP; Marimuthu T; Kumar P; du Toit LC; Pillay V Molecules; 2016 Nov; 21(11):. PubMed ID: 27879635 [TBL] [Abstract][Full Text] [Related]
25. Action of duck's egg white ovomucoid on tryptic hydrolysis of casein in vitro. VIJAYARAGHAVAN PK; NARASINGA RAO BS Nature; 1953 Dec; 172(4390):1152-3. PubMed ID: 13111276 [No Abstract] [Full Text] [Related]
26. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery. Kumar A; Lahiri SS; Singh H Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246 [TBL] [Abstract][Full Text] [Related]
27. [Properties of duck ovomucoid purified by affinity chromatography on trypsin-Sepharose]. Shul'gin MN; Valueva TA; Kestere AIa; Mosolov VV Biokhimiia; 1981 Mar; 46(3):473-80. PubMed ID: 6786376 [TBL] [Abstract][Full Text] [Related]
28. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397 [TBL] [Abstract][Full Text] [Related]
33. [For treatment of diseases involving the inner ear: the frontier of basic research]. Nakagawa T Nihon Jibiinkoka Gakkai Kaiho; 2008 Oct; 111(10):655-63. PubMed ID: 19119529 [No Abstract] [Full Text] [Related]
34. The influence of polymer architecture on the protective effect of novel comb shaped amphiphilic poly(allylamine) against in vitro enzymatic degradation of insulin--towards oral insulin delivery. Thompson CJ; Tetley L; Cheng WP Int J Pharm; 2010 Jan; 383(1-2):216-27. PubMed ID: 19766178 [TBL] [Abstract][Full Text] [Related]
35. A hydrogel based on a polyaspartamide: characterization and evaluation of in-vivo biocompatibility and drug release in the rat. Giammona G; Pitarresi G; Tomarchio V; Cacciaguerra S; Govoni P J Pharm Pharmacol; 1997 Nov; 49(11):1051-6. PubMed ID: 9401936 [TBL] [Abstract][Full Text] [Related]
36. Investigations on proteins and polymers. X. Composition and fractionation of ovomucoid. BIER M; TERMINIELLO L; DUKE JA; GIBBS RJ; NORD FF Arch Biochem Biophys; 1953 Dec; 47(2):465-73. PubMed ID: 13114916 [No Abstract] [Full Text] [Related]
37. Mucoadhesive polymers for oral transmucosal drug delivery: a review. Bagan J; Paderni C; Termine N; Campisi G; Lo Russo L; Compilato D; Di Fede O Curr Pharm Des; 2012; 18(34):5497-514. PubMed ID: 22632395 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of TRI-726 as a drug delivery matrix. Mondal P; Alur HH; Johnston TP Drug Dev Ind Pharm; 2011 Aug; 37(8):995-1001. PubMed ID: 21417600 [TBL] [Abstract][Full Text] [Related]
39. Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery. Shah RB; Khan MA J Pharm Sci; 2004 Feb; 93(2):392-406. PubMed ID: 14705196 [TBL] [Abstract][Full Text] [Related]
40. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery. Dilnawaz F Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]